It always doesn't turn out as they wish. Pharmac
Post# of 148189
Pharmacyclics trading around $1 and struggling, was sold for $261/shr just in half a decade later.
And that was over 20% premium over Janssen's bid, if I recall.
I'm here as, I have seen what happened to Pharmacyclics. Well, It takes time and there is a bit of risk. No so much, at this price.
Happy Holidays Everyone!